FDA aims to better understand immunotherapy in the ‘real world’ – OutSourcing-Pharma.com
OutSourcing-Pharma.com |
FDA aims to better understand immunotherapy in the 'real world'
OutSourcing-Pharma.com However, following FDA-approval of immunotherapies to treat various cancer, Kush explained the agency “wishes to better understand the safety effects of such drugs in the 'real world,' in addition to safety data from clinical trials.” To do so, the US … |
